Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes

PHASE1/PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

November 30, 2009

Study Completion Date

November 30, 2009

Conditions

Glucose IntoleranceType 2 Diabetes MellitusMetabolic Syndrome

Interventions

DRUG

Vitamin D3 2,000 IU orally once daily

DRUG

Calcium Carbonate 400 mg orally twice daily

DRUG

Vitamin D3-Placebo

DRUG

Calcium-Placebo

Trial Locations (1)

Tufts-New England Medical Center, Boston

All Listed Sponsors

collaborator

National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

NIH

lead

Tufts Medical Center

OTHER

NCT00436475 - Vitamin D and Calcium Homeostasis for Prevention of Type 2 Diabetes | Biotech Hunter | Biotech Hunter